Skip to main content

Advertisement

Log in

Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity

Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Background. Botulinum toxin type A (BoNTA) has been suggested as an effective anti-spastic drug. In this article, we summarized the data of randomized, placebo-controlled, double- blind trials and conducted a meta-analysis to assess if BoNTA is an adequate treatment for spasticity following stroke.

Objectives. To evaluate the relevant literature and assess the effectiveness and safety of BoNTA in (1) reducing spasticity based on mean change in the Modified Ashworth Scale (MAS) for upper and lower limb spasticity from baseline; (2) reducing spasticity based on the percent of patients having > or = 1point(s) change in the MAS; (3) improving the patient’s or caregivers’ Global Assessment Scale (GAS); and (4) total adverse events.

Method. We selected all randomized, placebo controlled, double-blind clinical trials or previous meta-analyses evaluating the efficacy and safety of BoNTA (Botox® or Dysport®) for the treatment of spasticity in both upper and lower limbs after stroke. Validity assessment of studies was performed, and Revman 4.2.7 from Cochrane Collaboration and SPSS (statistical package for the social sciences), v 9.0, were applied for analysis.

Results. Overall analysis showed clinical improvement between baseline and 4–6 weeks after application of BoNTA of the patient’s spasticity score using the MAS (weighted mean difference [WMD] = 0.87, 95% CI = 0.52–1.22). The odds ratio of the MAS spasticity score showing one or more points improvement at 4–6 weeks after giving BoNTA showed clinically significant improvement (OR = 4.5, 95% CI = 2.79–7.25). The odds ratio of having an improved GAS at 4–6 weeks after injecting BoNTA showed clinically significant improvement (Odds ratio = 5.85, 95% CI = 3.12–10.95). The odds ratio of having an adverse event during the entire study did not show any significant difference between placebo and BoNTA (odds ratio = 0.84, 95% CI = 0.55–1.28).

Reviewers’ conclusions. BoNTA improves muscle tone in upper and lower limb spasticity following stroke. A global assessment of improvement was noted by the patients or the caregivers following BoNTA injection. BoNTA is considered a safe therapeutic agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • AMO Bakheit S Pittock AP Moore et al. (2001) ArticleTitleA randomized double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke Eur J Neurol 8 559–565 Occurrence Handle11784339 Occurrence Handle10.1046/j.1468-1331.2001.00277.x Occurrence Handle1:STN:280:DC%2BD38%2FmvVynuw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • AMO Bakheit AF Thilman AB Ward et al. (2000) ArticleTitleA randomized double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type a with placebo in upper limb spasticity after stroke Stroke 31 2402–2406 Occurrence Handle11022071 Occurrence Handle1:CAS:528:DC%2BD3cXnsVKqtrg%3D

    PubMed  CAS  Google Scholar 

  • R Bohannon MB Smith (1987) ArticleTitleInter-rater reliability of the modified Ashworth scale of muscle spasticity Phys Ther 67 206–207 Occurrence Handle3809245 Occurrence Handle1:STN:280:DyaL2s7hvVCksg%3D%3D

    PubMed  CAS  Google Scholar 

  • A Brashear MF Gordon E Elovic et al. (2002) ArticleTitleIntra-muscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke New Engl J Med 347 395–400 Occurrence Handle12167681 Occurrence Handle10.1056/NEJMoa011892 Occurrence Handle1:CAS:528:DC%2BD38XlvFKrt7w%3D

    Article  PubMed  CAS  Google Scholar 

  • A Brashear A McAfee E Kuhn J Fyffe (2004) ArticleTitleBotulinum toxin type B in upper limb post-stroke spasticity: a double blind, placebo-controlled trial Arch Phys Med Rehab 85 705–709 Occurrence Handle10.1016/j.apmr.2003.08.077

    Article  Google Scholar 

  • P Burbaud L Wiart JL Dubos et al. (1996) ArticleTitleA randomized, double-blind, placebo-controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients J Neurol Neurosurg Psychiatry 61 265–269 Occurrence Handle8795597 Occurrence Handle1:STN:280:DyaK28zovVWqtA%3D%3D Occurrence Handle10.1136/jnnp.61.3.265

    Article  PubMed  CAS  Google Scholar 

  • E Cardoso B Rodrigues R Lucena et al. (2005) ArticleTitleBotulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis Arquives Neuropsiquiatry 63 30–33

    Google Scholar 

  • MK Childers A Brashear P Jozefczyk et al. (2004) ArticleTitleDose dependent response to intramuscular botulinum toxin type A for upper limb spasticity in patients after a stroke Arch Phys Med Rehab 85 1063–1069 Occurrence Handle10.1016/j.apmr.2003.10.015

    Article  Google Scholar 

  • HP Francis DT Wade L Turner-Stokes et al. (2004) ArticleTitleDoes reducing spasticity translate into functional benefit? An exploratory meta-analysis J Neurol Neurosurg Psychiatry 75 1547–1551 Occurrence Handle15489384 Occurrence Handle10.1136/jnnp.2003.025551 Occurrence Handle1:STN:280:DC%2BD2crhvVGqtg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • GE Francisco (2007) ArticleTitleBotulinum toxin for post-stroke spastic hypertonia: a review of its efficacy and application in clinical practice Ann Acad Med Singapore 36 22–30 Occurrence Handle17285183

    PubMed  Google Scholar 

  • L Fugoso RL Rosales M Delgado G Espiritu M Yusay G Salazar (2006) ArticleTitlePoststroke spasticity in the Philippines: definition, epidemiology and its pharmacologic therapy: a consensus statement of the Philippine Society of NeuroRehabilitation Neurorehab Neural Repair 20 IssueIDSuppl 198

    Google Scholar 

  • S Hesse F Reiter M Konrad et al. (1998) ArticleTitleBotulinum toxin type A and short term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized double blind, placebo controlled trial Clin Rehabil 12 381–388 Occurrence Handle9796928 Occurrence Handle10.1191/026921598668275996 Occurrence Handle1:STN:280:DyaK1M%2FhtV2msA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • T Mezaki R Kaji N Hirota et al. (1999) ArticleTitleTreatment of spasticity with muscle afferent block Neurology 53 1156–1157 Occurrence Handle10496293 Occurrence Handle1:STN:280:DyaK1MvisVKisA%3D%3D

    PubMed  CAS  Google Scholar 

  • MS Pathak HT Nguyen HK Graham AP Moore (2006) ArticleTitleManagement of spasticity in adults: practical application of botulinum toxin Eur J Neurol 13 IssueIDSuppl 42–50 Occurrence Handle16417597 Occurrence Handle10.1111/j.1468-1331.2006.01444.x

    Article  PubMed  Google Scholar 

  • SJ Pittock AP Moore O Hardiman et al. (2003) ArticleTitleA double blind randomized placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport®) in the treatment of spastic equinovarus deformity after stroke Cerebrovasc Dis 15 289–300 Occurrence Handle12686794 Occurrence Handle10.1159/000069495 Occurrence Handle1:CAS:528:DC%2BD3sXislKjsrk%3D

    Article  PubMed  CAS  Google Scholar 

  • RL Rosales H Bigalke D Dressler (2006) ArticleTitlePharmacology of botulinum toxin: differences between type A preparations Eur J Neurol 13 IssueIDSuppl 2–10 Occurrence Handle16417591 Occurrence Handle10.1111/j.1468-1331.2006.01438.x

    Article  PubMed  Google Scholar 

  • DM Simpson DN Alexander CF O’Brien et al. (1996) ArticleTitleBotulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial Neurology 46 1306–1310 Occurrence Handle8628472 Occurrence Handle1:STN:280:DyaK283ht1Gltw%3D%3D

    PubMed  CAS  Google Scholar 

  • SJ Smith E Ellis S White et al. (2000) ArticleTitleA double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury Clin Rehabil 14 5–13 Occurrence Handle10688339 Occurrence Handle10.1191/026921500666642221 Occurrence Handle1:STN:280:DC%2BD3c7ltFSntQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • DK Sommerfeld EUB Eek AK Svennson et al. (2004) ArticleTitleSpasticity after stroke Stroke 35 134–140 Occurrence Handle14684785 Occurrence Handle10.1161/01.STR.0000105386.05173.5E

    Article  PubMed  Google Scholar 

  • CL Watkins MJ Leathley JM Gregson et al. (2002) ArticleTitlePrevalence of spasticity post stroke Clin Rehabil 16 515–522 Occurrence Handle12194622 Occurrence Handle10.1191/0269215502cr512oa Occurrence Handle1:STN:280:DC%2BD38vjs1Ggug%3D%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. L. Rosales.

Additional information

Correspondence: Raymond L. Rosales, Units for Movement and Neuromuscular Disorders, Center for Neurodiagnostic/Therapeutic Services (CNS), Metropolitan Medical Center, Sta. Cruz, 1002 Manila, Philippines

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosales, R., Chua-Yap, A. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm 115, 617–623 (2008). https://doi.org/10.1007/s00702-007-0869-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-007-0869-3

Navigation